Raymond James & Associates’s Achilles Therapeutics ACHL Stock Holding History

Raymond James & Associates’s Portfolio ACHL Stock Details ACHL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$11.9K	Buy
2023 Q2	$12.4K	Buy